Recent Updates
Recently added Catalysts
SBFM

SUNSHINE BIOPHARMA ANNOUNCES THAT ESSENTIAL 9 IS NOW

Key Takeaway: SUNSHINE BIOPHARMA ANNOUNCES THAT ESSENTIAL 9 IS NOW AVAILABLE ON AMAZON.CA Quebec, Canada (ACCESSWIRE) Sunshine Biopharma, Inc. (OTC Markets: SBFM ) today announced that its recently launched micronutrients supplement, Essential now available on www.Amazon.ca. 14, 2018, He

Full Press Release Details

SUNSHINE BIOPHARMA ANNOUNCES THAT ESSENTIAL 9 IS NOW
AVAILABLE ON AMAZON.CA
Quebec, Canada (ACCESSWIRE) Sunshine Biopharma,
Inc. (OTC Markets: SBFM ) today announced that its
recently launched micronutrients supplement, Essential
now available on www.Amazon.ca.
14, 2018, Health Canada issued NPN 80089663 through which it
authorized Sunshine Biopharma to manufacture and sell the Essential
product. Essential 9TM is a dietary
supplement tablet that contains a balanced formula of the 9
essential amino acids that the human body cannot make. Sunshine
Biopharma anticipates that Essential 9TM will soon be
available on www.Amazon.com.
Essential Amino Acids are 9 out of the 20 amino acids required for
protein synthesis. Proteins are involved in all body functions
from the musculature and immune system to hormones and
neurotransmitters. Like
vitamins, Essential Amino Acids cannot be made by the human body
and must be obtained through diet. Deficiency in one or more of the
9 Essential Amino Acids can lead to loss of muscle mass, fatigue,
weight gain and reduced ability to build muscle mass in athletes.
Sunshine Biopharma's Essential 9TM
provides all 9 Essential Amino Acids
in freeform and in the proportions recommended by Health Canada.
is suitable for everyone: vegans,
athletes, seniors, dieters.
Safe Harbor Forward-Looking Statements
To the extent that statements in this press release are not
strictly historical, including statements as to revenue
projections, business strategy, outlook, objectives, future
milestones, plans, intentions, goals, future financial conditions,
future collaboration agreements, the success of the Company's
development, events conditioned on stockholder or other approval,
or otherwise as to future events, such statements are
forward-looking, and are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
The forward-looking statements contained in this release are
subject to certain risks and uncertainties that could cause actual
results to differ materially from the statements made.
For Additional Information:
Sunshine Biopharma, Inc.
Last updated: Mar 12, 2019